Redeye provides an update in relation to ISAB’s Q3 2023 report.
Fortsatt tillväxt i läkemedelsportföljen EQL Pharma rapporterade en tillväxt om 16,4 procent för de ...
On November 22nd, Eevia Health published the company’s quarterly report for Q3-23.
Redeye comments on the news yesterday that Carasent’s subsidiary, Metodika EPM signed, a contract wi...
Zoomability Int AB publicerade den 22 november 2023 bolagets delårsrapport för årets tredje kvartal.
Redeye comments on the postponement of the game Warhammer 40,000: Space Marine 2, now expected to be...
Focus in 2024e is on growth... ...while maintaining current EBITA margins amid operational leverage ...
Redeye comments on Heliospectra’s bride loan, announced last evening.
Catalyst växte med 155% under Q3’23 OssDsigns nettoomsättning för det tredje kvartalet 2023 uppgick ...
Cantargia går vidare mot fas 2-resultat i bolagets TRIFOUR-studie, stärkt av ett positivt utfall i d...
SRV’s CMD provided color on the company’s revised strategy and the path towards sustainable profitab...
Redeye returns with more insights on the Q3 report, and we continue to feel confident in OssDsign’s ...
Redeye leaves its initial comments in response to InDex Pharmaceuticals' announcement regarding the ...
Facing delays in both financing and operational development, the current cash at SEK 43.
74% FX-adj. sales growth in Q3, mainly driven by Catalyst Balance sheet strengthened through directe...
Organic sales decline of 6% y-o-y EBIT margin of 7.
Med årets tredje delårsrapport publicerad står det klart att Lucky Games följde upp föregående kvart...
Redye comments on the proposed rights issue of approximately SEK75m and bridge financing that was an...
Har lanserat fem intäktsbringande spel på global basis Gold Town Games AB (”Gold Town Games” eller ”...
Analysguidens förväntningar om ett positivt resultat grusades och kvartalets resultat kom in under f...
